Although these RasGEFs are potential oncogenes [42] and are known to activate Ras proteins by distinct mechanisms, it remained unclear whether differential expression of SOS1 and GRF2 is relevant in breast cancer. The gene discussed is RASGRF2; the disease is breast carcinoma.